XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Changes in Shareholders' Equity/(Deficit) - USD ($)
Preferred Stock
Series D Preferred Stock
Public Offering
Preferred Stock
Series D Preferred Stock
Common Stock
Public Offering
Common Stock
At Market Issuance sales
Common Stock
Pre-funded warrants
Common Stock
New Warrants
Common Stock
Existing Warrants
Common Stock
Additional Paid-In Capital
Public Offering
Additional Paid-In Capital
At Market Issuance sales
Additional Paid-In Capital
Pre-funded warrants
Additional Paid-In Capital
New Warrants
Additional Paid-In Capital
Existing Warrants
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Public Offering
At Market Issuance sales
Pre-funded warrants
New Warrants
Existing Warrants
Total
Balance at Dec. 31, 2022               $ 182           $ 217,067,691 $ 24,747 $ (219,563,446)           $ (2,470,826)
Balance (in shares) at Dec. 31, 2022               181,898                            
Balance at Dec. 31, 2022   $ 43                                        
Sale of common stock pursuant to B. Riley At Market Issuance Sales Agreement       $ 53           $ 3,091,409               $ 3,091,462        
Sale of common stock pursuant to B. Riley At Market Issuance Sales Agreement (in shares)       53,202                                    
Issuance costs associated with sales of common stock pursuant to At Market Issuance Sales Agreement                 $ (834,061) (95,348)             $ (834,061) (95,348)        
Redemption of Series D preferred stock   $ (43)                                        
Issuance of common stock and pre-funded warrants in connection with public offering     $ 144           8,495,673               8,495,817          
Issuance of common stock and pre-funded warrants in connection with public offering (in shares)     143,844                                      
Issuance of common stock to vendors               $ 3           72,997               73,000
Issuance of common stock to vendors (in shares)               3,125                            
Issuance of common stock upon exercise of warrants               $ 265           3,034               3,299
Issuance of common stock upon exercise of warrants (in shares)   0           264,714                            
Issuance of common stock for purchase option               $ 2           49,998               50,000
Issuance of common stock for purchase option (in shares)               1,978                            
Share-based compensation expense                           229,076               229,076
Foreign currency translation adjustment                             (429)             (429)
Net loss                               (4,320,835)           (4,320,835)
Balance at Sep. 30, 2023               $ 649           228,080,469 24,318 (223,884,281)           4,221,155
Balance (in Shares) at Sep. 30, 2023               648,761                            
Balance at Sep. 30, 2023   $ 0                                        
Balance (Shares) at Sep. 30, 2023   0                                        
Balance at Jun. 30, 2023               $ 615           228,015,103 6,061 (222,221,579)           5,800,200
Balance (in shares) at Jun. 30, 2023               615,236                            
Issuance of common stock upon exercise of warrants         $ 34           $ (34)                      
Issuance of common stock upon exercise of warrants (in shares)         33,525                                  
Share-based compensation expense                           65,400               65,400
Foreign currency translation adjustment                             18,257             18,257
Net loss                               (1,662,702)           (1,662,702)
Balance at Sep. 30, 2023               $ 649           228,080,469 24,318 (223,884,281)           4,221,155
Balance (in Shares) at Sep. 30, 2023               648,761                            
Balance at Sep. 30, 2023   $ 0                                        
Balance (Shares) at Sep. 30, 2023   0                                        
Balance at Dec. 31, 2023               $ 649           228,203,706 22,243 (225,704,176)           2,522,422
Balance (in shares) at Dec. 31, 2023               648,761                            
Balance at Dec. 31, 2023   $ 0                                        
Balance (Shares) at Dec. 31, 2023   0                                        
Issuance of common stock pursuant to At Market Issuance Sales Agreement       $ 15           58,421               58,436        
Issuance of common stock pursuant to At Market Issuance Sales Agreement (in shares)       14,883                                    
Issuance costs associated with sales of common stock pursuant to At Market Issuance Sales Agreement                 (625,065) (1,947)             (625,065) (1,947)        
Issuance of common stock and pre-funded warrants in connection with public offering $ 0   $ 205           $ 4,741,195               $ 4,741,400          
Issuance of common stock and pre-funded warrants in connection with public offering (in shares) 0   204,694                                      
Fractional shares issued in reverse stock split               $ 115           (115)                
Fractional shares issued in reverse stock split (in shares)               114,735                            
Issuance of common stock upon exercise of warrants         $ 537 $ 35 $ 703       $ 8,063 $ 222,787 $ 4,218,047           $ 8,600 $ 222,822 $ 4,218,750  
Issuance of common stock upon exercise of warrants (in shares)         537,500 34,816 703,125                              
Issuance costs associated with warrant inducement                           (7,552,457)               (7,552,457)
Warrant modification - incremental fair value                           7,177,683               7,177,683
Issuance of common stock associated with conversion of debt               $ 36           254,220               254,256
Issuance of common stock associated with conversion of debt (in shares)               36,790                            
Share-based compensation expense                           174,268               174,268
Foreign currency translation adjustment                             15,230             15,230
Net loss                               (5,279,210)           (5,279,210)
Balance at Sep. 30, 2024               $ 2,295           236,878,806 37,473 (230,983,386)           5,935,188
Balance (in Shares) at Sep. 30, 2024               2,295,304                            
Balance at Sep. 30, 2024   $ 0                                        
Balance (Shares) at Sep. 30, 2024   0                                        
Balance at Jun. 30, 2024               $ 1,542           232,699,640 27,599 (229,264,005)           3,464,776
Balance (in shares) at Jun. 30, 2024               1,542,480                            
Issuance of common stock pursuant to At Market Issuance Sales Agreement       $ 15           58,421               58,436        
Issuance of common stock pursuant to At Market Issuance Sales Agreement (in shares)       14,883                                    
Issuance costs associated with sales of common stock pursuant to At Market Issuance Sales Agreement                   $ (1,947)               $ (1,947)        
Issuance of common stock upon exercise of warrants           $ 35 $ 703         $ 222,787 $ 4,218,047             $ 222,822 $ 4,218,750  
Issuance of common stock upon exercise of warrants (in shares)           34,816 703,125                              
Issuance costs associated with warrant inducement                           (7,552,457)               (7,552,457)
Warrant modification - incremental fair value                           7,177,683               7,177,683
Share-based compensation expense                           56,632               56,632
Foreign currency translation adjustment                             9,874             9,874
Net loss                               (1,719,381)           (1,719,381)
Balance at Sep. 30, 2024               $ 2,295           $ 236,878,806 $ 37,473 $ (230,983,386)           $ 5,935,188
Balance (in Shares) at Sep. 30, 2024               2,295,304                            
Balance at Sep. 30, 2024   $ 0                                        
Balance (Shares) at Sep. 30, 2024   0